摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-heptyl-4-hydroxy-3-octanoyl-2H-pyran-2-one | 107617-15-2

中文名称
——
中文别名
——
英文名称
6-heptyl-4-hydroxy-3-octanoyl-2H-pyran-2-one
英文别名
6-Heptyl-4-hydroxy-3-octanoyl-pyran-2-one;6-heptyl-4-hydroxy-3-octanoylpyran-2-one
6-heptyl-4-hydroxy-3-octanoyl-2H-pyran-2-one化学式
CAS
107617-15-2
化学式
C20H32O4
mdl
——
分子量
336.472
InChiKey
UXMFHBGEDUHLJO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.9
  • 重原子数:
    24
  • 可旋转键数:
    13
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    63.6
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    6-heptyl-4-hydroxy-3-octanoyl-2H-pyran-2-one硫酸 作用下, 反应 1.0h, 以69%的产率得到6-庚基-4-羟基吡喃-2-酮
    参考文献:
    名称:
    脂肪酸合成的天然产物抑制剂:海洋微生物代谢产物假吡喃酮A和B的合成及其抗感染活性的评估
    摘要:
    使用甲基β-氧代羧酸酯原料已完成标题天然产物假吡喃酮A(1)和B(2)的总合成。天然产物和少量组结构上相关的化合物用于针对一系列病原微生物的生长抑制活性进行了评价,发现其显示出良好的效力(IC 50 ≥0.46微克/毫升),并选择性向杜氏利什曼原虫。几种化合物抑制了恶性疟原虫和结核分枝杆菌的重组脂肪酸生物合成酶,从而在寻找新的抗感染药时验证了这些靶标。
    DOI:
    10.1016/j.tet.2007.11.075
  • 作为产物:
    描述:
    3-氧代癸酸N,N'-羰基二咪唑 作用下, 以 四氢呋喃 为溶剂, 反应 24.0h, 以2.522 g的产率得到6-heptyl-4-hydroxy-3-octanoyl-2H-pyran-2-one
    参考文献:
    名称:
    分离抗生素假吡喃乙并评估C3 / C6烷基类似物的SAR。
    摘要:
    天然产物是具有抗菌活性的结构多样的化合物的丰富来源,可用于开发新型有效的抗生素。一类这样的天然产物是假吡喃酮。在这里,我们介绍了从北卡罗莱纳州西部花园土壤中发现的假单胞菌属物种中分离出假吡喃酮B(2),以及对天然产物的C3和C6烷基类似物对革兰氏阳性和革兰氏阴性细菌的抗菌活性的SAR评估。我们发现抗菌活性和C3 / C6烷基链长之间存在直接关系。为了抑制革兰氏阳性菌,发现6​​至7个碳原子之间的烷基链长度最活跃(IC50 = 0.04-3.8µg / mL),而短链烷基类似物对革兰氏阴性菌的活性中等(IC50 = 223) -304µg / mL)。
    DOI:
    10.1016/j.bmcl.2017.04.067
点击查看最新优质反应信息

文献信息

  • Natural product inhibitors of fatty acid biosynthesis: synthesis of the marine microbial metabolites pseudopyronines A and B and evaluation of their anti-infective activities
    作者:Anna C. Giddens、Lone Nielsen、Helena I. Boshoff、Deniz Tasdemir、Remo Perozzo、Marcel Kaiser、Feng Wang、James C. Sacchettini、Brent R. Copp
    DOI:10.1016/j.tet.2007.11.075
    日期:2008.2
    Total syntheses of the title natural products, pseudopyronines A (1) and B (2), have been achieved using methyl β-oxo carboxylic ester starting materials. The natural products and a small set of structurally related compounds were evaluated for growth inhibitory activity against a range of pathogenic microorganisms and were found to exhibit good potency (IC50≥0.46 μg/mL) and selectivity towards Leishmania
    使用甲基β-氧代羧酸酯原料已完成标题天然产物假吡喃酮A(1)和B(2)的总合成。天然产物和少量组结构上相关的化合物用于针对一系列病原微生物的生长抑制活性进行了评价,发现其显示出良好的效力(IC 50 ≥0.46微克/毫升),并选择性向杜氏利什曼原虫。几种化合物抑制了恶性疟原虫和结核分枝杆菌的重组脂肪酸生物合成酶,从而在寻找新的抗感染药时验证了这些靶标。
  • Structural Basis for the Formation of Acylalkylpyrones from Two β-Ketoacyl Units by the Fungal Type III Polyketide Synthase CsyB
    作者:Takahiro Mori、Dengfeng Yang、Takashi Matsui、Makoto Hashimoto、Hiroyuki Morita、Isao Fujii、Ikuro Abe
    DOI:10.1074/jbc.m114.626416
    日期:2015.2
    The acylalkylpyrone synthase CsyB from Aspergillus oryzae catalyzes the one-pot formation of the 3-acyl-4-hydroxy-6-alkyl-alpha-pyrone scaffold from acetoacetyl-CoA, fatty acyl-CoA, and malonyl-CoA. This is the first type III polyketide synthase that performs not only the polyketide chain elongation but also the condensation of two beta-ketoacyl units. The crystal structures of wild-type CsyB and its
    米曲霉的酰基烷基吡喃酮合酶CsyB催化由乙酰乙酰辅酶A,脂肪酰基辅酶A和丙二酰辅酶A一锅形成3-酰基-4-羟基-6-烷基-α-吡喃酮支架。这是第一种III型聚酮化合物合酶,不仅可以进行聚酮化合物链的延伸,还可以使两个β-酮酰基单元缩合。野生型CsyB及其I375F和I375W突变体的晶体结构分别以1.7-,2.3-和2.0-A的分辨率解析。晶体结构揭示了一个独特的活性位点结构,该结构具有迄今无法识别的新颖口袋,可容纳乙酰乙酰辅酶A起始物,此外还具有带有Cys-His-Asn催化三联体的常规延伸/环化口袋和用于结合脂肪的长疏水通道酰基链。该结构还表明存在一个假定的亲核水分子,该分子被氢键网络激活,其活性位点中心处有His-377和Cys-155。此外,体外酶反应证实,H2(18)O分子的(18)O原子通过酶法结合到最终产物中。这些观察结果表明,酶反应是通过将乙酰乙酰辅酶A负载到Cys-155
  • Inhibition of human sputum elastase by substituted 2-pyrones. 2
    作者:Luisa Cook、Bela Ternai、Peter Ghosh
    DOI:10.1021/jm00389a010
    日期:1987.6
    Nineteen 4-hydroxy- and 4-methoxy-2-pyrones related to elasnin (I) have been assayed for in vitro inhibition of human sputum elastase (HSE), porcine pancreatic elastase, alpha-chymotrypsin, and trypsin. Inhibition is reported as Ki and Ki'; percentage inhibition was dependent on [S] in a number of cases, making it unsuitable as a measure of relative inhibition. The 3-(1-oxoalkyl)-4-hydroxy-6-alkyl-2-pyrones were found to be most effective, the octyl homologue 11 being the most potent inhibitor (Ki = 4.6 microM, 30 times better than the lead compound). A further reduction in inhibition was observed when the hitherto hydrophobic 6-substituent was substituted by a branched functionality of hydrophilic nature. Conversely, methylation of the 4-hydroxy group of the 6-alkyl-2-pyrones increased inhibitory activity. The mechanism of inhibition varied from pure noncompetitive to mixed type to uncompetitive and was found to be dependent on the pattern of substitution. We believe that the 4-hydroxy-2-pyrone binds to the S4 subsite, with the 6-substituent extending across the S4-S1 subsites and the 3-substituent occupying the S5 subsite. The length of the inhibitor binding region was calculated to be approximately 24 A. None of the hydrophobic compounds were found to have any appreciable inhibition (less than 10%) with porcine pancreatic elastase, bovine alpha-chymotrypsin, and bovine trypsin when tested at the limit of their solubility. The hydrophilic compounds were nonspecific, inhibiting all four enzymes. Dialysis was used to show that the interaction is fully reversible.
  • EP0365539A4
    申请人:——
    公开号:EP0365539A4
    公开(公告)日:1990-12-05
  • HUMAN LEUCOCYTE ELASTASE INHIBITOR COMPOUNDS
    申请人:AUSTRALIAN COMMERCIAL RESEARCH & DEVELOPMENT LIMITED
    公开号:EP0365539A1
    公开(公告)日:1990-05-02
查看更多